Bausch Health
226 hedge funds and large institutions have $1.99B invested in Bausch Health in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 53 increasing their positions, 77 reducing their positions, and 24 closing their positions.
67% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 24
7% more funds holding
Funds holding: 212 → 226 (+14)
0.67% less ownership
Funds ownership: 69.58% → 68.91% (-0.67%)
11% less capital inflows, than outflows
Capital inflows: $126M | Capital outflows: $142M
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
31% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 77
58% less call options, than puts
Call options by funds: $37.8M | Put options by funds: $89.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Maple Rock Capital Partners
Toronto,
Ontario, Canada
|
+$26.7M |
| 2 |
Compass Rose Asset Management
New York
|
+$13.6M |
| 3 |
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$12.8M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$12.5M |
| 5 |
SG Americas Securities
New York
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$24.6M |
| 2 |
Goldman Sachs
New York
|
-$24.4M |
| 3 |
Goldentree Asset Management
New York
|
-$15.3M |
| 4 |
Eversept Partners
New York
|
-$12.5M |
| 5 |
Soleus Capital Management
Greenwich,
Connecticut
|
-$11.6M |
BHC Hedge Fund Activity: Q4 2024 in Review
226 of the 7,617 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2024, worth a combined $1.99B — down 4.5% from $2.09B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new BHC positions and 24 closed out — a net gain of 16 holders — while 53 added to existing stakes and 77 trimmed.
The largest buyer was Maple Rock Capital Partners, adding an estimated $26.7M. The largest seller was Bank of Montreal, cutting an estimated $24.6M.
- 226 institutional investors held Bausch Health (BHC) as of Q4 2024, up from 212 in Q3 2024.
- Funds reported $1.99B of Bausch Health stock for Q4 2024, down 4.5% quarter-over-quarter.
- 40 funds opened new Bausch Health positions in Q4 2024 and 24 closed out, a net change of +16 holders.
- The largest Bausch Health buyer in Q4 2024 was Maple Rock Capital Partners, an estimated $26.7M added.
- The largest Bausch Health seller in Q4 2024 was Bank of Montreal, an estimated $24.6M sold.
Based on aggregated 13F filings for Q4 2024.